RE:RE:RE:The plant checkpoints are obviously done: Hey DryBones, so you're saying that they are lying on the MD&A? You've been here a long time. Have you challenged management with your accusations? What have they said? It's clear that they seem to be cleanly through those process controls from 2 communications after Q3'19. Are you just speculating or do you have some theory or evidence to share?
DryBones wrote: Nothing more can be expected of LMNL until management finally concedes and admits that the checkpoint quality control issue cannot be solved The purification process must be written off as a technologicial failure. To get Ryplazim and the clinical trials approved by the FDA will require purchase from other sources. Then they must license that methodology ;the cone process. This business of proping up the stock with buys way over the ask will not save Thomies big investment. The Tomies should give up their nasty deception and let the SP find its value, which is less than a buck.AS for the rest of us, we are all losers, learn to live with it.